---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-050249"
form_type: "8-K"
ticker: "ORKA"
cik: "0000907654"
company_name: "Oruka Therapeutics, Inc."
filed_at: "2026-04-30T23:59:59+00:00"
generated_at: "2026-05-15T01:27:18.859690+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Oruka Therapeutics closes 9.66M-share offering at $72.50; prelim cash $496M

## Summary
- Oruka completed underwritten public offering of 9,660,000 shares of common stock at $72.50 per share, raising gross proceeds of approximately $700 million.
- Underwriters have a 30-day option to purchase up to an additional 1,449,000 shares at the public offering price.
- Preliminary estimate of cash, cash equivalents, and investments as of March 31, 2026 is approximately $496 million.
- Offering closed April 30, 2026; underwriting agreement dated April 28, 2026 with Leerink, TD, Goldman Sachs, Stifel, Guggenheim.

## SEC filing metadata
- accession: 0001213900-26-050249
- form_type: 8-K
- ticker: ORKA
- cik: 0000907654
- company_name: Oruka Therapeutics, Inc.
- filed_at: 2026-04-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/907654/000121390026050249/0001213900-26-050249-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/907654/000121390026050249/ea0288461-8k_oruka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-050249
- JSON: https://secwatch.observer/filing/0001213900-26-050249.json
- Plain text: https://secwatch.observer/filing/0001213900-26-050249.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.